Grace Therapeutics, Inc.
GRCE · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $22 | $23 | $28 | $30 |
| Short-Term Investments | $0 | $0 | $0 | $13 |
| Receivables | $0 | $1 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $1 | $1 |
| Total Curr. Assets | $23 | $24 | $29 | $46 |
| Property Plant & Equip (Net) | $0 | $0 | $1 | $0 |
| Goodwill | $8 | $8 | $8 | $13 |
| Intangibles | $41 | $41 | $41 | $70 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $49 | $49 | $50 | $83 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $72 | $73 | $79 | $129 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $3 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $1 | $2 | $0 |
| Total Curr. Liab. | $2 | $2 | $3 | $3 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2 | $6 | $7 | $17 |
| Other NC Liab. | $1 | $4 | $0 | $0 |
| Total NC Liab. | $3 | $10 | $8 | $17 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $5 | $12 | $11 | $20 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $261 | $258 | $258 |
| Retained Earnings | -$221 | -$211 | -$198 | -$156 |
| AOCI | -$6 | -$6 | -$6 | -$6 |
| Other Equity | $293 | $18 | $14 | $12 |
| Total Equity | $67 | $62 | $68 | $108 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $72 | $73 | $79 | $129 |
| Net Debt | -$22 | -$23 | -$27 | -$30 |